Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. MRK has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
MRK stock price ended at $75.97 on Friday, after losing-2.16%
The Merck & Co Inc stock price decreased by -2.16% on the last trading day (09 May 2025), dropping from 77.96 to 75.97. Throughout the last trading session, the stock experienced a fluctuation of 3.47% , ranging from a day low of $75.82 to a day high of 78.45. The price has declined in 6 of the last 10 days, resulting in a total change of -8.18% during this period. On the last day, trading volume increase by 555.49K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 15.61M shares were traded, amounting to approximately 1.20B.
MRK Technical Signals
MRK(Merck & Co Inc Corp) has 3 buy signals and 5 sell signals now. The current trend is uptrend starting from 2025-04-10. The total price change during this trend is -2.04%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of MRK over the last 5 trading days is 1.08B. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
MRK Moving Average Analysis
Merck & Co Inc's overall moving average trend leans more bearish as of Saturday, May 10, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $87.20818, and $91.032. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $74.83581999999998, and $71.01199999999999. A break-down below any of these levels will issue sell signals.
MRK Short Selling Analysis
The short sale ratio of Merck & Co Inc(MRK) as of 09 May 2025 is 15.85%, dropping from last trading day. With decreasing price from 77.65 to 75.97. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
Sell
5
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
16.52
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
13.301
Bullish
Williams %R (14 days)
WILLR_14 < -80
-98.501
Bullish
5 Bearish Signals
5 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-2.96
Bearish
Momentum (10 days)
MOM_10 < 0
-6.77
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-1.665
Bearish
Closing price
close < fibonacci_S1
75.97
Bearish
Moving Average
5-day SMA crosses below 20-day SMA
--
Bearish
MRK Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Merck & Co Inc(MRK), our algorithm predicts MRK's 1-month price at $93.07, with an 11.89%upwardshift. Using a similarity score up to 97.48%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Merck & Co Inc (MRK.N) stock, as of Sunday, May 4, 2025 , forecasts a 11.89% change over the next month, based on its high correlation with MNSO.N stock patterns. The similarity between their price movements over the analyzed periods is 97.48%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
MRK
Future prediction
Up: 11.89%
MNSO
Up: 11.89%Similarity: 97.48%
Name
Similarity
Up/Down
MNSO.N
97.48%
+11.89%
PFE.N
97.06%
-7.93%
NKTR.O
97.04%
-28.57%
AGNC.O
96.94%
0.00%
AX.N
96.89%
+20.18%
XERS.O
96.87%
-11.23%
ALTO.O
96.85%
+4.42%
SAP.N
96.80%
-2.59%
CNK.N
96.66%
+8.96%
FPI.N
96.61%
+5.92%
MRK Seasonality Analysis
Based on MRK's historical stock price data across all years, the probability of a positive return in May is72.73%, suggesting it maybe an ideal month to invest in MRK. In contrast,Marchoffers the highest probability of positive returns at72.73%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Merck & Co Inc (MRK.N) stock in March has the highest probability of a positive return (72.73%), while February has the lowest probability (27.27%).
Performance Seasonality
The chart shows Merck & Co Inc. (MRK)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. MRK has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Merck & Co Inc (MRK.N) stock in a year?
The radar chart shows that buying Merck & Co Inc (MRK.N) stock in March has the highest probability of a positive return (72.73%), while February has the lowest probability (27.27%).
How has Merck & Co Inc. (MRK)'s stock price performed over the past three years?
MRK's stock price rose by 0.84% in 2023,decreased by -9.75% in 2024, and went down by 23.39% in 2025.
Bearish technical signals of MRK include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0, close < fibonacci_S1, 5-day SMA crosses below 20-day SMA.
Is MRK a buy based on overall technical signals summary?
MRK has 3 buy signals and 5 sell signals now. Overall the technical rating for MRK is Sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of MRK.
What is the trend of Merck & Co Inc (MRK)'s moving average?
Merck & Co Inc's overall moving average trend leans more bearish as of May 10 2025, with 4 negative signals and 0 positive signal.
What is price prediction for MRK stock next month?
The price prediction chart for Merck & Co Inc (MRK.N) stock, as of May 04 2025, forecasts a 11.89% change over the next month, based on its high correlation with MNSO stock patterns. The similarity between their price movements over the analyzed periods is 97.48%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for MRK Stock?
MRK stock is expected to reach **$110-$115** in 2025, driven by strong Keytruda sales growth and pipeline advancements. The stock faces headwinds from declining Gardasil sales in China and weaker-than-expected 2025 guidance. Analysts maintain a "Strong Buy" consensus with a mean target of **$125.95**.
What is price prediction 2030 for MRK Stock?
### **Price Prediction for MRK Stock by 2030**
MRK stock is expected to reach **$115 by 2030**, driven by continued growth of Keytruda and new product launches. The stock is currently undervalued with a forward P/E of 9.24, offering upside potential. Analysts predict strong earnings growth and a robust pipeline.